Condition: Reasoning


rs2142694 in CYP2D7;LOC105377203 gene and Reasoning PMID 27046643 2016 Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151).

rs74412765 in EGLN3;EGLN3-AS1;LOC102724945 gene and Reasoning PMID 29907492 2018 Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.

rs76872642 in HDAC9 gene and Reasoning PMID 29907492 2018 Genome-wide association analyses identified loci associated with attention/vigilance (rs830786 within HNF4G), verbal memory (rs67017972 near NDUFS4), and reasoning/problem solving (rs76872642 within HDAC9).

rs2833556 in HUNK gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

rs4611189 in LRRC4C gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

rs2286720 in LYZL4 gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

rs17108533 in MAP3K9 gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

rs9771228 in PDE1C gene and Reasoning PMID 27046643 2016 Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151).

rs3753242 in PRKCZ gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

rs17706989 in WWOX gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

rs17689437 in ZFP90 gene and Reasoning PMID 21107309 2011 Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.